Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Smart hydrogel dressings could improve diabetic wound healing by adjusting to wound conditions and controlling drug release.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

FGF12 is important for hair growth and could be targeted for hair loss treatment.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Fusarium sp. strain K-23 helps Arabidopsis plants grow better in salty soil by promoting root hair growth.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Regenerative cosmetics can improve skin and hair by reducing wrinkles, healing wounds, and promoting hair growth.

The developed system could effectively treat hair loss and promote hair growth.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Porcine skin is very similar to human skin, making it a useful model for research.

Western diet may cause male pattern baldness; low glycemic diet with magnesium could help.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.